首页> 外国专利> ANTIGEN DISCOVERY FOR T CELL RECEPTORS ISOLATED FROM PATIENT TUMORS RECOGNIZING WILD-TYPE ANTIGENS AND POTENT PEPTIDE MIMOTOPES

ANTIGEN DISCOVERY FOR T CELL RECEPTORS ISOLATED FROM PATIENT TUMORS RECOGNIZING WILD-TYPE ANTIGENS AND POTENT PEPTIDE MIMOTOPES

机译:从患者肿瘤中识别出T细胞受体的抗原发现,该肿瘤识别野生型抗原和潜在肽多态性

摘要

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 27 September 2018 (27.09.2018) o n °nolo VIII (10) International Publication Number WO 2018/175585 A3 WIPO I PCT (51) International Patent Classification: C12Q 1/68 (2018.01) C12N 15/09 (2006.01) (21) International Application Number: PCT/US2018/023569 (22) International Filing Date: 21 March 2018 (21.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/476,575 24 March 2017 (24.03.2017) US (71) Applicant: THE BOARD OF TRUSTEES OF THE LE- LAND STANFORD JUNIOR UNIVERSITY [US/US]; Office of the General Counsel, Building 170, 3rd Floor, Main Quad P.O. Box 20386, Stanford, California 94305-2038 (US). (72) Inventors: GEE, Marvin; 2100 Geng Road, Suite 200, Palo Alto, California 94303 (US). DAVIS, Mark M.; 52 Euclid Avenue, Atherton, California 94027 (US). HAN, Arnold; 81 Walworth Avenue, Scarsdale, New York 10583 (US). GARCIA, Kenan Christopher; 580 Kenwood Dri- ve, Menlo Park, California 94025 (US). = (74) Agent: SHERWOOD, Pamela J.; Bozicevic, Field & Francis LLP, 201 Redwood Shores Parkway, Suite 200, Redwood City, California 94065 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). W O 20 18/ 1755 85 A3 Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) — before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a)) (88) Date of publication of the international search report: 01 November 2018 (01.11.2018) (54) Title: ANTIGEN DISCOVERY FORT CELL RECEPTORS ISOLATED FROM PATIENT TUMORS RECOGNIZING WILD- TYPE ANTIGENS AND POTENT PEPTIDE MIMOTOPES (57) : Compositions and methods are provided for peptide sequences that are ligands for a T cell receptor (TCR) of interest, in a given MHC context.
机译:根据专利合作条约(PCT)发行的国际申请(19)世界知识产权组织国际局(43)国际公告发布日期为2018年9月27日(27.09.2018),关于第8号公告(10)国际公告号WO 2018/175585 A3 WIPO I PCT(51)国际专利分类:C12Q 1/68(2018.01)C12N 15/09(2006.01)(21)国际申请号:PCT / US2018 / 023569(22)国际申请日期:2018年3月21日(2018年3月21日) (25)申请语言:英语(26)出版语言:英语(30)优先数据:62 / 476,575 2017年3月24日(2017年3月24日)美国(71)申请人:兰德·斯坦福初中大学董事会美国/美国];总公司办公室三楼170楼总法律顾问办公室Box 20386,Stanford,California 94305-2038(US)。 (72)发明人:GEE,Marvin; 2100 Geng Road,Suite 200,Palo Alto,California 94303(US)。戴维斯,马克M。加利福尼亚州阿瑟顿市Euclid Avenue 52号,美国94027。韩,阿诺德;纽约州斯卡斯代尔市沃尔沃斯大街81号,美国10583。加西亚,基南·克里斯托弗; 580 Kenwood Drive,门洛帕克,加利福尼亚州94025(美国)。 =(74)代理:SHERWOOD,Pamela J .; Bozicevic,Field&Francis LLP,201 Redwood Shores Parkway,Suite 200,Redwood City,California 94065(US)。 (81)指定国家(除非另有说明,对于每种可用的国家保护):AE,AG,AL,AM,AO,AT,AU,AZ,BA,BB,BG,BH,BN,BR,BW,BY ,BZ,CA,CH,CL,CN,CO,CR,CU,CZ,DE,DJ,DK,DM,DO,DZ,EC,EE,EG,ES,FI,GB,GD,GE,GH,GM ,GT,HN,HR,HU,ID,IL,IN,IR,IS,JO,JP,KE,KG,KH,KN,KP,KR,KW,KZ,LA,LC,LK,LR,LS,LU ,LY,MA,MD,ME,MG,MK,MN,MW,MX,MY,MZ,NA,NG,NI,NO,NZ,OM,PA,PE,PG,PH,PL,PT,QA,RO ,RS,RU,RW,SA,SC,SD,SE,SG,SK,SL,SM,ST,SV,SY,TH,TJ,TM,TN,TR,TT,TZ,UA,UG,US,UZ ,VC,VN,ZA,ZM,ZW。 (84)指定国家(除非另有说明,对于每种可用的区域保护):ARIPO(BW,GH,GM,KE,LR,LS,MW,MZ,NA,RW,SD,SL,ST,SZ,TZ ,UG,ZM,ZW),欧亚(AM,AZ,BY,KG,KZ,RU,TJ,TM),欧洲(AL,AT,BE,BG,CH,CY,CZ,DE,DK,EE,ES ,FI,FR,GB,GR,HR,HU,IE,IS,IS,IT,LT,LU,LV,MC,MK,MT,NL,NO,PL,PT,RO,RS,SE,SI,SK,SM ,TR),OAPI(BF,BJ,CF,CG,CI,CM,GA,GN,GQ,GW,KM,ML,MR,NE,SN,TD,TG)。 WO 20 18/1755 85 A3根据细则4.17所作的声明:-发明人权利(细则4.17(iv))已发布:-附有国际检索报告(第21条第(3)款)-在修改权利要求和将在收到修订的情况下重新发布(细则48.2(h)),并包含描述的序列表部分(细则5.2(a))(88)国际检索报告的发布日期:2018年11月1日(01.11.2018) (54)标题:从识别野生型抗原和潜在肽多态性的患者肿瘤中分离出的抗原发现堡细胞受体(57):提供了肽序列的组合物和方法,所述肽序列是目标T细胞受体(TCR)的配体给定的MHC环境。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号